Human leukocyte antigens as genetic markers in greek patients with sporadic pancreatic cancer

Pancreas

Volumn 29, Issue 1, 2004, Pages 41-44

  Kouerinis, Ilias A ^a,c   Zografos, G ^a   Tarassi, K E ^b   Athanasiades, T H ^b   Liontos, M ^a   Gorgoulis, V G ^a   Korkolis, D ^a   Konstandoulakis, M M ^a   Fotiadis, C I ^a   Androulakis, G ^a   Papasteriades, C A ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

DNA extraction; Embryology; Genetic markers; HLA; Immunology; Pancreatic cancer

Indexed keywords

HLA A31 ANTIGEN; HLA A3O ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B18 ANTIGEN; HLA CW7 ANTIGEN; LEUKOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANTIGEN DETECTION; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GREECE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; SEROLOGY;

AGED; AGED, 80 AND OVER; ALCOHOLISM; ANTIGENS, NEOPLASM; COMORBIDITY; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENES, MHC CLASS I; GENES, MHC CLASS II; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS;

EID: 3042773143     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200407000-00054     Document Type: Article

References (30)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer Statistics. Cancer J Clin. 2002;52:23-47.
2. Almoguera C, Shibata D, Forrester K, et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988;53:549-554.
3. Wilentz RE, Geradts J, Maynard R, et al. Inactivation of the p16 (INK4A) tumour-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res. 1998;58:4740-4744.
4. Barton CM, Staddon SL, Hughes CM, et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer. 1991; 64:1076-1082.
5. Hahn SA, Hoque AT, Moshaluk CA, et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 1996;56:490-494.
6. Konner J, O'Reilly E. Pancreatic cancer: epidemiology, genetics, and approaches to screening. Oncology. 2002;16(12):1615-11623.
7. Juhasz F, Boros P, Swegedi G, et al. Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer. 1989;63:1318-1326.
8. Rigopoulou D, Martinez-Laso J, Martinez-Tello F, et al. Both class I and class II antigens are thyroid cancer susceptibility factors. Tissue Antigens. 1994;43:281-285.
9. Wang R, Thomsen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQW3. Nature. 1991;352:723-725.
10. Barger BO, Acton RT, Soong SJ, Roseman J, Balch C. Increase of HLA-DR4 in melanoma patients from Alabama. Cancer Res. 1982;42:4276.
11. Lee JE, Reveille JD, Ross MI, Platsoucas CD. HLA-DQB1*0301 association with increased cutaneous melanoma risk. Int J Cancer. 1994;59: 510-513.
12. Kratzik C, Aiginger P, Kuber W, et al. Risk factors for bilateral testicular germ cell tumors. Cancer. 1991;68:916-921.
13. Sory A, Gorski A, Misiuna P, Wallner G, Polkowski W. Is gastric cancer heterogeneity the clue to HLA-DR associated susceptibility? Acta Oncol. 1994;33:976-977.
14. Hilton DA, West KP. An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma. Cancer. 1990;66:1154-1157.
15. Levin VI, Muravskaia GV, Buglova EE, et al. The distribution of HLA-system in lung cancer patients. Vopr Oncol. 1991;37:280-283.
16. Toumbis M, Zervas J, Anagnostopulou O, et al. HLA antigens and bronchogenic carcinoma in the Greek population. Acta Oncol. 1991;30:575-578.
17. Chatzipetrou MA, Tarassi KE, Konstadoulakis MM, et al. Human leukocyte antigens as genetic markers in colorectal carcinoma. Dis Colon Rectum. 1991;42:66-70.
18. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature. 1964;204:998-1000.
19. Buyse I, Decorte R, Baens M, et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens. 1993;41:1-14.
20. Oterup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens. 1992;39:225-35.
21. Vartdal F, Gaudernack G, Funderud S, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation-a fast and reliable technique. Tissue Antigens. 1986;28:301-312.
22. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleid Acids Res. 1988;16:1215-1218.
23. Lee JE, Lowy Am, Thompson WA, et al. Association of gastric adenocarcinoma with the HLA class II gene DQB1031. Gastroenterology. 1996;111(2):426-432.
24. Dardari R, Jouhadi H, Benider A, et al. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma. Int J Cancer. 2001;92:294-297.
25. Chan SH, Chew CT, Prasad U, Wee GB, Srinivasan N, Kunaratnam N. HLA and nasopharyngeal carcinoma in Malays. Brit J Cancer. 1985;51: 389-392.
26. Silvermann DT, Dunn JA, Hoover RN, et al. Cigarette smoking and pancreas cancer: a case control study based on direct interviews. J Natl Cancer Inst. 1994;86(20):1510-1516.
27. La Vecchia C, Boyle P, Franceschi S, et al. Smoking and cancer with emphasis on Europe. Eur J Cancer. 1991;27(1):94-104.
28. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT. A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res. 2002;62(16):4630- 4636.
29. Lee HC, Yoon YB, Kim CY. Association between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6 and 2E1) and the susceptibility to pancreatic cancer. Korean J Intern Med. 1997;12(2):128-136.
30. Cowgill SM, Muscarella P. The genetics of pancreatic cancer. Am J Surg. 2003;186(3):279-86.